These final results, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 help the concept of targeting ACKR3 as a unique way to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked Conditions. The complement is developed https://richardn693cba4.life-wiki.com/user